Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 79.61
+5.05 (6.77%)
At close: Sep 30, 2026
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 11.32 billion as of October 2, 2026. Its market cap has increased by 50.66% in one year.
Market Cap
11.32B
Enterprise Value
10.36B
Revenue
630.86M
Ranking
n/a
PE Ratio
120.25
Stock Price
79.61
ChartMarket Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has increased from 10.43B to 11.32B, an increase of 8.52%. That is a compound annual growth rate of 2.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 11.32B | 102.97% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
| Sep 2, 2022 | 10.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jinyu Bio-technology | 12.65B |
| Chengdu Olymvax Biopharmaceuticals | 12.65B |
| Inner Mongolia Furui Medical Science | 12.44B |
| Hualan Biological Vaccine | 11.97B |
| Mabwell (Shanghai) Bioscience | 11.61B |
| Novoprotein Scientific | 11.15B |
| InventisBio | 11.05B |
| Tibet Cheezheng Tibetan Medicine | 10.99B |